Formulation of intravenous carbamazepine emulsions by SolEmuls technology
- PMID: 12754005
- DOI: 10.1016/s0939-6411(03)00028-6
Formulation of intravenous carbamazepine emulsions by SolEmuls technology
Abstract
Oil in water (O/W) emulsions for parenteral nutrition can be employed as intravenous (i.v.) carriers for drugs that are poorly soluble in water and in oil by localising the drug in the interfacial lecithin layer, e.g. Amphotericin B emulsions. By now, the emulsion production required organic solvents. SolEmuls technology localises the drug in the interfacial layer by a solvent-free high-pressure homogenisation process. SolEmuls was applied to produce Carbamazepine emulsions at increasing drug concentrations from 0.5 to 10mg/ml. Drug powder and Lipofundin emulsion were mixed and homogenised at 1500bar. Characterisation of emulsions and short-term stability were performed by photon correlation spectroscopy (PCS) and laser diffractometry. Drug incorporation (absence of non-dissolved drug crystals) was investigated by light microscopy and a centrifugation test. The emulsions were physically stable and complete drug dissolution is possible up to 3mg/ml. Up to 10mg/ml drug hybrid dispersions of emulsion droplets and ultrafine nanocrystals were obtained. Both, emulsions and hybrid dispersions are suitable as i.v. injectables regarding size and stability.
Similar articles
-
Solubilizing poorly soluble antimycotic agents by emulsification via a solvent-free process.AAPS PharmSciTech. 2004 Apr 2;5(1):E24. doi: 10.1208/pt050124. AAPS PharmSciTech. 2004. PMID: 15198542 Free PMC article.
-
SolEmuls-novel technology for the formulation of i.v. emulsions with poorly soluble drugs.Int J Pharm. 2004 Jan 28;269(2):293-302. doi: 10.1016/j.ijpharm.2003.09.019. Int J Pharm. 2004. PMID: 14706241
-
Intravenous itraconazole emulsions produced by SolEmuls technology.Eur J Pharm Biopharm. 2003 Jul;56(1):29-36. doi: 10.1016/s0939-6411(03)00063-8. Eur J Pharm Biopharm. 2003. PMID: 12837478
-
Oil-in-water lipid emulsions: implications for parenteral and ocular delivering systems.Prog Lipid Res. 2004 Nov;43(6):489-533. doi: 10.1016/j.plipres.2004.09.001. Prog Lipid Res. 2004. PMID: 15522762 Review.
-
Design and production of nanoparticles formulated from nano-emulsion templates-a review.J Control Release. 2008 Jun 24;128(3):185-99. doi: 10.1016/j.jconrel.2008.02.007. Epub 2008 Feb 23. J Control Release. 2008. PMID: 18374443 Review.
Cited by
-
Injectable lipid emulsions-advancements, opportunities and challenges.AAPS PharmSciTech. 2010 Dec;11(4):1526-40. doi: 10.1208/s12249-010-9526-5. Epub 2010 Oct 26. AAPS PharmSciTech. 2010. PMID: 20976577 Free PMC article. Review.
-
Solubilizing poorly soluble antimycotic agents by emulsification via a solvent-free process.AAPS PharmSciTech. 2004 Apr 2;5(1):E24. doi: 10.1208/pt050124. AAPS PharmSciTech. 2004. PMID: 15198542 Free PMC article.
-
Honokiol-Loaded Nanoemulsion for Glioblastoma Treatment: Statistical Optimization, Physicochemical Characterization, and an In Vitro Toxicity Assay.Pharmaceutics. 2023 Jan 29;15(2):448. doi: 10.3390/pharmaceutics15020448. Pharmaceutics. 2023. PMID: 36839769 Free PMC article.
-
Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability.AAPS PharmSciTech. 2012 Dec;13(4):1483-91. doi: 10.1208/s12249-012-9876-2. Epub 2012 Oct 23. AAPS PharmSciTech. 2012. PMID: 23090113 Free PMC article.
-
Microemulsions and Nanoemulsions in Skin Drug Delivery.Bioengineering (Basel). 2022 Apr 5;9(4):158. doi: 10.3390/bioengineering9040158. Bioengineering (Basel). 2022. PMID: 35447718 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources